The Administration of Ocoxin Increases the Quality of Life of Patients with Advanced Epithelial or Metastatic Ovarian Cancer Undergoing Neoadjuvant Chemotherapy

    January 2022 in “ Journal of Cancer Therapy ”
    Karen López Miguel, Daniel Ricardo Martínez Ávila, Lliset Álvarez Pérez, Gisselle Martínez Rabasa, Alejandro Linchenat Lambert, Roberto Esperón Noa, Lisandra Heredia Manzano, Margarita De Quesada Amigó, Rafael I. Reyes Velázquez, Danay Corrales Otero, Ramón Ropero Toirac, Idelmis Curbelo Heredia, Mircea Betancourt Cabeza, Tania A. Agrelo Ramos, Rosa María Muñoz Reyes, Juan J. Lence Anta, Rosalía Fuentes Sosa, Karelia Silvera Candó, Kirenia Silva Rodríguez, Zaida Lastre Sosa, Mayte Robaina García, Eduardo Sanz, David X. Márquez
    TLDR Ocoxin improves quality of life for advanced ovarian cancer patients on chemotherapy.
    The administration of Ocoxin in patients with advanced epithelial or metastatic ovarian cancer undergoing neoadjuvant chemotherapy significantly improved their quality of life. The study, involving 36 patients, reported a statistically significant increase in the global health status/QoL scale and improvements in symptoms such as fatigue, loss of appetite, and insomnia. Despite the occurrence of 290 adverse events, most were mild or moderate, and only 15 were serious, with none related to Ocoxin. The Karnofsky index improved in 86.1% of patients, indicating better functional status. However, there was a significant decrease in BMI and body weight, highlighting the need for nutritional support during treatment.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 1000+ results

      community Alopecia Areata Question

      in Treatment  2 upvotes 3 years ago
      A user with alopecia totalis, borderline universalis, seeks advice on getting into a Xeljanz trial or appealing insurance for coverage. They experienced significant hair regrowth but are now seeing hair loss again and want to try Xeljanz.

      community mbp alopecia areata or vitamin deficiency

      in Chat 4 months ago
      A 19-year-old male has been using topical finasteride and minoxidil for 8 months with no progress and is considering seeking a second opinion due to potential misdiagnosis. The discussion revolves around whether the hair loss is due to male pattern baldness, alopecia areata, or a vitamin deficiency.

      community Androgenic alopecia exclusively on the vertex of the scalp

      in Chat  6 upvotes 6 months ago
      A user experienced androgenic alopecia starting at the vertex without frontal hairline recession and is seeking information on this pattern. Another user noted that vertex or diffuse hair loss is common among men.

      community Fibrosing alopecia in a pattern distribution

      in Research/Science  14 upvotes 8 months ago
      A user has been experiencing hair loss for 4 years, with treatments like minoxidil, finasteride, and various supplements proving ineffective. They were diagnosed with fibrosing alopecia in a pattern distribution, a condition that may require a combination of anti-inflammatory and hair growth treatments.

      community Androgenetic alopecia is a skin disease: DHT-mediated skin disorders

      in Research/Science  65 upvotes 1 year ago
      Dihydrotestosterone (DHT) impacts various skin conditions, including Androgenetic alopecia and seborrheic dermatitis, by causing overactivity in sebaceous glands. Topical medications Tacrolimus and Clobetasol can reduce these inflammatory conditions, and treatments like RU58841, Minoxidil, and Finasteride may also be beneficial.

    Similar Research

    5 / 1000+ results